Literature DB >> 21327455

Multidisciplinary considerations in the implementation of the findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 study: a practice-changing trial.

Abigail S Caudle, Kelly K Hunt, Henry M Kuerer, Funda Meric-Bernstam, Anthony Lucci, Isabelle Bedrosian, Gildy V Babiera, Rosa F Hwang, Merrick I Ross, Barry W Feig, Karen Hoffman, Jennifer K Litton, Aysegul A Sahin, Wei Yang, Gabriel N Hortobagyi, Thomas A Buchholz, Elizabeth A Mittendorf.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 21327455      PMCID: PMC4332388          DOI: 10.1245/s10434-011-1593-7

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  21 in total

1.  Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer.

Authors:  G Cserni; D Gregori; F Merletti; A Sapino; M P Mano; A Ponti; S Sandrucci; B Baltás; G Bussolati
Journal:  Br J Surg       Date:  2004-10       Impact factor: 6.939

2.  Analysis of axillary coverage during tangential radiation therapy to the breast.

Authors:  Julia Reznik; M Giulia Cicchetti; Barbara Degaspe; T J Fitzgerald
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-01-01       Impact factor: 7.038

3.  Relationship of sentinel and axillary level I-II lymph nodes to tangential fields used in breast irradiation.

Authors:  P J Schlembach; T A Buchholz; M I Ross; S M Kirsner; G J Salas; E A Strom; M D McNeese; G H Perkins; K K Hunt
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-11-01       Impact factor: 7.038

4.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

Authors:  D J Slamon; W Godolphin; L A Jones; J A Holt; S G Wong; D E Keith; W J Levin; S G Stuart; J Udove; A Ullrich
Journal:  Science       Date:  1989-05-12       Impact factor: 47.728

5.  Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.

Authors:  Armando E Giuliano; Kelly K Hunt; Karla V Ballman; Peter D Beitsch; Pat W Whitworth; Peter W Blumencranz; A Marilyn Leitch; Sukamal Saha; Linda M McCall; Monica Morrow
Journal:  JAMA       Date:  2011-02-09       Impact factor: 56.272

6.  Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Authors:  Martine J Piccart-Gebhart; Marion Procter; Brian Leyland-Jones; Aron Goldhirsch; Michael Untch; Ian Smith; Luca Gianni; Jose Baselga; Richard Bell; Christian Jackisch; David Cameron; Mitch Dowsett; Carlos H Barrios; Günther Steger; Chiun-Shen Huang; Michael Andersson; Moshe Inbar; Mikhail Lichinitser; István Láng; Ulrike Nitz; Hiroji Iwata; Christoph Thomssen; Caroline Lohrisch; Thomas M Suter; Josef Rüschoff; Tamás Suto; Victoria Greatorex; Carol Ward; Carolyn Straehle; Eleanor McFadden; M Stella Dolci; Richard D Gelber
Journal:  N Engl J Med       Date:  2005-10-20       Impact factor: 91.245

7.  Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.

Authors:  Edward H Romond; Edith A Perez; John Bryant; Vera J Suman; Charles E Geyer; Nancy E Davidson; Elizabeth Tan-Chiu; Silvana Martino; Soonmyung Paik; Peter A Kaufman; Sandra M Swain; Thomas M Pisansky; Louis Fehrenbacher; Leila A Kutteh; Victor G Vogel; Daniel W Visscher; Greg Yothers; Robert B Jenkins; Ann M Brown; Shaker R Dakhil; Eleftherios P Mamounas; Wilma L Lingle; Pamela M Klein; James N Ingle; Norman Wolmark
Journal:  N Engl J Med       Date:  2005-10-20       Impact factor: 91.245

8.  Association between extent of axillary lymph node dissection and survival in patients with stage I breast cancer.

Authors:  J A Sosa; M Diener-West; Y Gusev; M A Choti; J R Lange; W C Dooley; M A Zeiger
Journal:  Ann Surg Oncol       Date:  1998-03       Impact factor: 5.344

9.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

Authors:  D J Slamon; G M Clark; S G Wong; W J Levin; A Ullrich; W L McGuire
Journal:  Science       Date:  1987-01-09       Impact factor: 47.728

10.  Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.

Authors:  Karl Y Bilimoria; David J Bentrem; Nora M Hansen; Kevin P Bethke; Alfred W Rademaker; Clifford Y Ko; David P Winchester; David J Winchester
Journal:  J Clin Oncol       Date:  2009-04-13       Impact factor: 44.544

View more
  29 in total

Review 1.  What can we learn from oncology surgical trials?

Authors:  Serge Evrard; Pippa McKelvie-Sebileau; Cornelis van de Velde; Bernard Nordlinger; Graeme Poston
Journal:  Nat Rev Clin Oncol       Date:  2015-10-20       Impact factor: 66.675

Review 2.  Trends and controversies in multidisciplinary care of the patient with breast cancer.

Authors:  Laura S Dominici; Monica Morrow; Elizabeth Mittendorf; Jennifer Bellon; Tari A King
Journal:  Curr Probl Surg       Date:  2016-11-29       Impact factor: 1.909

Review 3.  Consensus on the regional lymph nodes irradiation in breast cancer.

Authors:  E Bayo; I Herruzo; M Arenas; M Algara
Journal:  Clin Transl Oncol       Date:  2013-03-22       Impact factor: 3.405

4.  Radiation field design in the ACOSOG Z0011 (Alliance) Trial.

Authors:  Reshma Jagsi; Manjeet Chadha; Janaki Moni; Karla Ballman; Fran Laurie; Thomas A Buchholz; Armando Giuliano; Bruce G Haffty
Journal:  J Clin Oncol       Date:  2014-08-18       Impact factor: 44.544

5.  Is intraoperative imprint cytology evaluation still feasible for the evaluation of sentinel lymph nodes for lobular carcinoma of the breast?

Authors:  Marissa Howard-McNatt; Kim R Geisinger; John H Stewart; Perry Shen; Edward A Levine
Journal:  Ann Surg Oncol       Date:  2011-08-31       Impact factor: 5.344

6.  Axillary Management in Women with Early Breast Cancer and Limited Sentinel Node Metastasis: A Systematic Review and Metaanalysis of Real-World Evidence in the Post-ACOSOG Z0011 Era.

Authors:  Tzu-Wen Huang; Chih-Ming Su; Ka-Wai Tam
Journal:  Ann Surg Oncol       Date:  2020-07-23       Impact factor: 5.344

7.  Impact of the American College of Surgeons Oncology Group (ACOSOG) Z0011 trial on clinical management of the axilla in older breast cancer patients: a SEER-medicare analysis.

Authors:  Holly Caretta-Weyer; Caprice G Greenberg; Lee G Wilke; Jennifer Weiss; Noelle K LoConte; Marquita Decker; Nicole M Steffens; Maureen A Smith; Heather B Neuman
Journal:  Ann Surg Oncol       Date:  2013-12       Impact factor: 5.344

8.  Preoperative axillary ultrasound in breast cancer: safely avoiding frozen section of sentinel lymph nodes in breast-conserving surgery.

Authors:  Irada Ibrahim-Zada; Clive S Grant; Katrina N Glazebrook; Judy C Boughey
Journal:  J Am Coll Surg       Date:  2013-04-28       Impact factor: 6.113

9.  Predictive value of fine needle aspiration biopsy of axillary lymph nodes in preoperative breast cancer staging.

Authors:  Muzaffer Akıncı; Serap Pamak Bulut; Fazilet Erözgen; Mihriban Gürbüzel; Gökçe Gülşen; Ahmet Kocakuşak; Mehmet Gülen; Rafet Kaplan
Journal:  Ulus Cerrahi Derg       Date:  2016-04-06

10.  American College of Surgeons Oncology Group (ACOSOG) Z0011: impact on surgeon practice patterns.

Authors:  Abigail S Caudle; Kelly K Hunt; Susan L Tucker; Karen Hoffman; Sarah M Gainer; Anthony Lucci; Henry M Kuerer; Funda Meric-Bernstam; Ruchita Shah; Gildy V Babiera; Aysegul A Sahin; Elizabeth A Mittendorf
Journal:  Ann Surg Oncol       Date:  2012-07-31       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.